Ninety-Six Minutes to the First Dose: Adults With Sickle Cell Disease in a Community Emergency Department and the Gap in Pain Care
Student Name
American College of Education
NUR5033: Advanced Nursing and Practice II
Module 1 Assignment
Instructor Name
July 5, 2027
The Population
Sickle cell disease is an inherited disorder in which abnormal hemoglobin causes red blood cells to become rigid and sickle-shaped under stress, blocking small blood vessels and producing sudden, severe pain known as a vaso-occlusive crisis. Adults with the disease may experience several crises a year, and many are managed at home, but severe episodes bring people to the emergency department, where the first hours of care determine how quickly pain is controlled and whether admission can be avoided. In the United States the disease affects mainly people of African descent, which means that the quality of emergency care for sickle cell pain is also a question about racial equity.
The population for this course is adults aged 18 and older with sickle cell disease who present to the emergency department of a 280-bed community hospital with a vaso-occlusive crisis. None of the hospital, its figures or its patients is real; all are invented to model the analysis. Over the most recent twelve months, 41 adults with sickle cell disease made 118 emergency department visits for pain crises. Nine patients accounted for 64 of the visits, a concentration typical of this population, in which a minority with the most severe disease use emergency care most often. The nearest comprehensive sickle cell center is ninety minutes away, so most of these patients have no specialist on site when they arrive in pain.
The Standard of Care
The national standard for the first hours of care is clear on its central point. An expert panel convened by the National Heart, Lung, and Blood Institute issued evidence-based recommendations for managing sickle cell disease and included among its strong recommendations the rapid initiation of opioids for severe pain associated with a vaso-occlusive crisis (Yawn et al., 2014). The panel's guidance specified that analgesia should begin within 30 minutes of triage or within 60 minutes of registration, with pain reassessed and doses repeated at short intervals until pain is controlled.
The American Society of Hematology later issued guidelines on acute and chronic pain in sickle cell disease that used the GRADE approach and reached 18 recommendations (Brandow et al., 2020). Because much of the underlying evidence is of low certainty, most of those recommendations are conditional, and the panel emphasized that patient preferences should drive decisions. The guidelines nonetheless support rapid, individualized assessment and treatment of acute pain in the emergency department. The standard does not depend on a single study; it reflects a consensus that severe pain in this disease is an emergency to be treated within the first hour.
Measuring the Gap
A review of the 118 visits measured the time from triage to the first dose of parenteral opioid. The median was 96 minutes, with an interquartile range of 58 to 147 minutes. Only 27 of the 118 visits, 23 percent, reached a first dose within 60 minutes of triage, and 6 visits, 5 percent, within 30 minutes. Pain was reassessed within 60 minutes of the first dose in 49 visits, 42 percent. For comparison, the same hospital's median time from triage to first opioid dose for patients with a long bone fracture, a condition of similar pain severity, was 44 minutes over the same period.
The pattern of delay was not random. Visits by the nine most frequent users had a median time to first dose of 112 minutes, compared with 71 minutes for the other 32 patients. Nurses and physicians interviewed informally described uncertainty about appropriate doses for patients on long-term opioids, difficulty obtaining intravenous access in patients with scarred veins and, in two cases, concern that a patient was seeking drugs. The patients who come most often, who usually have the most severe disease, wait the longest.
Why the Gap Exists
Some of the delay has practical causes: dosing uncertainty for opioid-tolerant patients, difficult venous access and crowded departments. Some of it has a more troubling cause. Haywood et al. (2013) compared emergency department wait times for patients with sickle cell disease with those of a general patient sample and of patients with long bone fractures. Patients with sickle cell disease waited 25 percent longer than the general sample, a difference explained by their race, and 50 percent longer than patients with long bone fracture even after accounting for race and assigned triage level. The authors concluded that both race and the diagnosis of sickle cell disease itself contribute to longer waits.
The local data are consistent with that finding. The comparison with fracture patients at the same hospital shows a gap of 52 minutes in median time to first dose for pain of similar severity. The longer waits for frequent visitors suggest that familiarity with a patient, which might be expected to speed care, may instead attach a label that slows it. None of this means that individual clinicians intend to delay care, but it does mean that the gap cannot be explained by workload alone.
What the Gap Costs
The delay has consequences beyond discomfort. Pain that is not controlled early in a crisis tends to require more medication later, and patients whose pain is still severe several hours after arrival are more likely to be admitted. In the twelve months reviewed, 71 of the 118 visits, 60 percent, ended in admission, and the median length of those admissions was four days. The review could not show how many admissions a faster first dose would have prevented, but it does show that the department's current approach leads most visits into the hospital.
The delay also shapes what patients expect. Several of the most frequent visitors described, in a patient advisory group meeting the hospital held last year, arriving already prepared to wait and to argue for treatment, and some said they delay coming in until their pain is unbearable because the wait is so long. That pattern can make the next crisis worse and the next visit more difficult for everyone involved. A gap measured in minutes becomes, over months, a relationship of mistrust between a department and the patients who depend on it most.
The Gap Statement
Stated in one sentence, the gap is this: adults with sickle cell disease in a vaso-occlusive crisis at this community emergency department wait a median of 96 minutes from triage to their first opioid dose, with fewer than one in four treated within the hour recommended by national guidance, and they wait about twice as long as patients with fractures of similar pain, with the longest delays falling on the patients with the most frequent and severe crises. The rest of this course will appraise the evidence for closing that gap, design a change, test it against the realities of staffing, scope and cost, and decide how its effect will be measured.
Conclusion
The population in this paper is small in number and large in need: 41 adults with a painful, lifelong disease whose crises bring them to a community emergency department without specialist support. The national standard calls for pain treatment to begin within the first hour, and local data show that it usually does not, with a pattern of delay that mirrors published evidence on disparities in emergency care for this group. Defining the population and measuring the gap precisely is the foundation for everything the course asks next, because a gap stated in minutes and proportions can be closed and shown to be closed.
References
Brandow, A. M., Carroll, C. P., Creary, S., Edwards-Elliott, R., Glassberg, J., Hurley, R. W., Kutlar, A., Seisa, M., Stinson, J., Strouse, J. J., Yusuf, F., Zempsky, W., & Lang, E. (2020). American Society of Hematology 2020 guidelines for sickle cell disease: Management of acute and chronic pain. Blood Advances, 4(12), 2656-2701. https://doi.org/10.1182/bloodadvances.2020001851
Haywood, C., Jr., Tanabe, P., Naik, R., Beach, M. C., & Lanzkron, S. (2013). The impact of race and disease on sickle cell patient wait times in the emergency department. The American Journal of Emergency Medicine, 31(4), 651-656. https://doi.org/10.1016/j.ajem.2012.11.005
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., Tanabe, P. J., Ware, R. E., Murad, M. H., Goldsmith, J. C., Ortiz, E., Fulwood, R., Horton, A., & John-Sowah, J. (2014). Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA, 312(10), 1033-1048. https://doi.org/10.1001/jama.2014.10517
How this NUR 5033 Module 1 example is structured
NUR 5033 Module 1 often defines the composite population and the gap in care the paper will argue about; your classroom's instructions decide the population and whether local data are required. This example describes the population clinically and in numbers, sets out the national standard with its source, measures local performance against it and then examines why the gap exists, including the evidence on bias in emergency care for this group. It ends with a one-sentence gap statement. Defining the standard before the local data lets the reader see the gap for themselves rather than taking the writer's word for it.
NUR5033 Module 1 questions, answered
What does NUR5033 Module 1 usually ask for?
NUR5033 Module 1 often asks students to define a composite population and a gap in the care it receives, which the rest of the course will address. Many sections expect the population to be described with numbers and the gap measured against a named standard. Your classroom's instructions decide the population, the setting and the format.
How do I measure a gap in care for a paper?
Name the standard first, with its source, then measure local performance against it using the same definition, for example minutes from triage to first dose. Report medians, proportions meeting the target and, if possible, a comparison group. Explain how the data were gathered and note any limits.
Should a gap paper discuss bias or disparities?
If the evidence shows that the gap falls unequally on a group, yes. Cite research that has measured the disparity, compare it with your local data and describe it carefully, focusing on patterns and systems rather than individual intent. That analysis often explains a gap that workload alone cannot.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official American College of Education document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.